γ secretase(aβ)

DAPT (LY-374973) 是一种 γ 分泌酶抑制剂，抑制总 Aβ 和 Aβ42 (IC50=115 200 nM)，具有口服活性。DAPT 也是一种 Notch 抑制剂。DAPT 可以诱导细胞分化、诱导细胞自噬和凋亡。

gamma-secretase modulator 1 是一种 γ 分泌酶的调节剂，可用于治疗阿尔茨海默病的研究。

gamma-secretase modulator 2 is a potent and selective γ-secretase modulator for treatment of Alzheimer's disease .γ-secretase modulator is modulation of the action of γ-secretase so as to Selectively attenuate production of Aβ(1-42) and hence find use in treatment or prevention of diseases associated with deposition of Aβ in the brain. γ-secretase modulator is usful in particular Alzheimer's disease.

gamma-secretase inhibitior-1 是γ-secretase 调节剂，gamma-secretase inhibitior-1可用于阿尔茨海默病。

γ-Secretase modulator 4 is a potent γ-secretase modulator, reduces the Aβ42 level with IC50s of 0.017 μM and 0.014 μM in mouse and human, respectively.

gamma-Secretase Modulators serves as a useful treatment for Alzheimer's disease by inhibiting the production of Amyloid-β. Specifically, it acts as a gamma-Secretase Modulators with an IC50 value.

β-Secretase Inhibitor IV is a potent, cell-active inhibitor of BACE-1(IC50s of 15.6 and 16.3nM under BACE-1 concentrations of 2 nM and 100 pM, respectively).

BACE-IN-1 是淀粉样前体蛋白 β-分泌酶抑制剂。

β-Secretase Inhibitor I is a highly potent inhibitor of the β-secretase enzyme. This compound exhibits exceptional inhibitory activity while also demonstrating a significant reduction in cardiovascular and liver toxicity.

β-Secretase Inhibitor II is a tripeptide aldehyde compound that acts as an inhibitor of β-Secretase. It exhibits a simple structure and has an inhibitory potency of IC50 = 700 nM against total Aβ and IC50 = 2.5 μM specifically against Aβ 1-42. This compound is particularly useful in research related to Alzheimer's disease.

γ-Secretase modulator 10 is a novel γ-secretase modulator.

γ-Secretase modulator 12 (Compound 1a) is a selective compound that effectively reduces amyloid-β42 (Aβ42) levels with an IC50 of 0.39 μM. It is specifically designed for Alzheimer's disease research. Notably, γ-Secretase modulator 12 exhibits a favorable brain plasma ratio (Kp, brain = 0.72) in mice [1].

β-Secretase Inhibitor III 是一种高度选择性的 BACE1 抑制剂，其 Ki 值为 0.13 nM。

5-{8-[（3，4'-二氟[1，1'-联苯]-4-基）甲氧基]-2-甲基咪唑并[1，2-a]吡啶-3-基}-N-甲基吡啶-2-甲酰胺（1o）具有较高的体外效力和脑暴露效果，能够使脑Aβ42水平的明显降低，且对细胞色素p450酶无抑制作用。此外，化合物1o 在AD 模型小鼠中表现出优异的抗认知缺陷作用。

γ-Secretase modulator 11 hydrochloride 是有效的、口服具有活力的 γ-secretase 调节剂 (IC50: 0.029 μM)。 γ-Secretase modulator 11 hydrochloride 能够明显降低脑 Aβ42 水平，可挽救 AD 模型小鼠表现出的认知缺陷。γ-Secretase modulator 11 hydrochloride 对阿尔茨海默病表现出研究潜力。

gamma-secretase modulator 5 (compound 22d) 是一种能够透过血脑屏障的 γ-分泌酶调节剂 (GSMs)，对聚集的淀粉样蛋白 β 肽 Aβ42 的产生表现出抑制作用 (IC50: 60 nM)。gamma-secretase modulator 5 能够用于研究阿尔茨海默病。

γ-Secretasemodulator 14 是一种 γ-分泌酶 (γ-secretase) 调节剂，具有用于阿尔茨海默病 (AD) 研究的潜力 (WO2013010904A1; compound 42)。

γ-secretase-IN-2 (Compound 36) 作为一种γ-secretase的抑制剂, 其IC50值为0.07 nM。

δ-secretase inhibitor 11是一种分泌酶抑制剂，可用作 阿尔茨海默病（AD） 治疗转化开发的先导化合物。

BMS 433796 是一种在阿尔茨海默病转基因小鼠模型中具有Aβ降低活性的γ分泌酶抑制剂，可有效抑制 Aβ 的产生。

Aβ-IN-1 是一种新型有效且具有口服活性的 γ 分泌酶调节剂 (GSM)。 Aβ-IN-1 在不抑制 CYP3A4 的情况下，在培养细胞中有效降低 Aβ42 水平，IC50值为 0.091 μM。Aβ-IN-1 显示出良好的药代动力学特征。

BMS 299897 是一种磺胺类 γ 分泌酶抑制剂。它在稳定过表达淀粉样前体蛋白（APP）的 HEK293 细胞中抑制 Aβ 生成的 IC50 值为 7 nM。

3,5-Bis(4-nitrophenoxy)benzoic acid (Compound W) 是 γ-secretase 抑制剂。它导致 Aβ42 和 notch-1 Aβ-like peptide 25 (Nβ25) 的释放水平降低。它是母体血清中 3,3’-diiodothyronine sulfate (T2S) 的交叉反应物质，可作为胎儿甲状腺功能减退的标志物。

Aftin-4 是一种 β-淀粉样蛋白42(Aβ42) 的诱导剂。